Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult
Clinical trial NCT06099613 · COMPLETED
Trial details
- NCT number
- NCT06099613
- Sponsor
- EyeGene Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2024-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.